Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Roche Inks 'The Largest Obesity Deal To Date' With Zealand Pharma At $5.3 Billion
In This Article:
Roche and Zealand Pharma inked a $5.3 billion deal Wednesday to collaborate on a weight-loss drug in the amylin class.
Terms and Privacy Policy